Roche Holding AG (OTCMKTS:RHHBY) Stock Has Average Target Price of $60.00

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been given an average rating of “Moderate Buy” by the fourteen analysts that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $60.00.

RHHBY has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft raised shares of Roche from a “hold” rating to a “buy” rating in a research note on Friday, October 23rd. Royal Bank Of Canada started coverage on shares of Roche in a research report on Tuesday, September 8th. They set an “outperform” rating for the company. Zacks Research upgraded Roche from a “strong sell” rating to a “hold” rating in a report on Monday, August 24th. Morgan Stanley upgraded shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price target on the stock in a research report on Friday, August 7th. Finally, Oddo Bhf raised Roche to an “outperform” rating in a research report on Tuesday, October 20th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in RHHBY. First Command Advisory Services Inc. lifted its position in Roche by 188.7% during the third quarter. First Command Advisory Services Inc. now owns 37,694 shares of the company’s stock worth $1,956,000 after purchasing an additional 24,639 shares during the period. Associated Banc Corp purchased a new position in Roche during the 3rd quarter worth $1,740,000. Woodstock Corp acquired a new stake in shares of Roche in the 3rd quarter worth $245,000. GAMMA Investing LLC grew its position in Roche by 15.3% during the 3rd quarter. GAMMA Investing LLC now owns 33,458 shares of the company’s stock worth $1,736,000 after purchasing an additional 4,443 shares during the last quarter. Finally, Renasant Bank acquired a new stake in shares of Roche during the 2nd quarter worth $210,000.

Roche Stock Down 0.1%

OTCMKTS RHHBY opened at $59.37 on Friday. Roche has a 1-year low of $41.43 and a 1-year high of $61.49. The business has a 50 day moving average price of $55.86 and a 200 day moving average price of $53.88. The company has a quick ratio of 0.95, a current ratio of 1.23 and a debt-to-equity ratio of 0.69.

Roche Company Profile

Roche is a Swiss healthcare company with two main businesses: pharmaceuticals and diagnostics. Founded in Basel in 1896, the company develops and commercializes medicines and provides diagnostic tests, instruments, and digital health solutions.

Its pharmaceutical research and products span areas including oncology, immunology, neuroscience, ophthalmology, and infectious diseases. Its diagnostics business serves clinical laboratories, hospitals, healthcare providers, and patients with tools used to detect and monitor a range of medical conditions.

Headquartered in Basel, Roche operates in markets around the world.